Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%0700.HK-6.19%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.76%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-1.46%UNH-10.21%1288.HK-1.64%PM-0.85%0005.HK-2.09%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.56%EURAUD+1.01%AUDCHF-0.99%AUDCAD-0.99%GBPAUD+0.93%AUDNZD-0.88%NZDJPY-0.82%GBPJPY-0.76%CADJPY-0.71%EURJPY-0.71%CHFJPY-0.70%NZDUSD-0.67%AUDSGD-0.62%GBPUSD-0.61%USDCHF+0.60%USDCAD+0.58%AUDDKK-0.56%EURUSD-0.56%USDZAR+0.44%GBPTRY+0.41%USDMXN+0.41%AUDNOK-0.37%USDTHB+0.35%NZDMXN+0.32%GBPHKD+0.32%EURZAR+0.31%USDNOK+0.30%GBPMXN-0.28%GBPZAR+0.28%CHFNOK+0.26%NOKJPY-0.24%USDTRY+0.21%USDSEK+0.19%EURNOK+0.19%USDPLN+0.17%USDILS+0.16%USDJPY-0.15%EURCNH-0.15%CHFSEK+0.14%EURHKD-0.13%USDCNH-0.12%NZDCAD-0.12%USDDKK+0.12%EURNZD+0.11%NZDCHF-0.11%GBPSGD-0.09%PLNJPY-0.09%EURSEK+0.08%EURGBP+0.06%GBPNZD+0.06%USDSGD+0.06%EURSGD-0.06%GBPCAD-0.05%EURPLN+0.05%EURCZK+0.04%EURCHF+0.04%USDCOP-0.04%SGDJPY+0.02%GBPCHF-0.02%EURCAD+0.02%USDHKD-0.01%CADCHF+0.01%NZDSGD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.14%XAGUSD-0.95%GAGUSD-0.95%XAUUSD-0.64%GAUUSD-0.64%HG1-0.53%W1-0.47%XNGUSD-0.44%C1-0.29%UKOIL+0.28%S1-0.15%USOIL+0.05%BTCUSD-3.70%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.67%ZECUSDT-7.39%XMRUSDT-2.17%DOGEUSD+55.95%LINKUSD-3.57%XLMUSD-3.94%BCHUSDT-3.64%LTCUSD+47.50%UNIUSD-3.19%SUIUSD-3.36%TONUSD+59.18%HBARUSDT-5.48%TAOUSDT-3.60%AAVEUSD-3.76%ONDOUSDT-5.67%ICPUSDT-2.09%DOTUSDT-4.17%WLDUSDT-3.94%ARBUSDT-5.98%ATOMUSDT-2.61%INJUSDT-8.15%STXUSDT-3.46%PYTHUSDT-1.58%TIAUSDT-3.65%FETUSDT-4.91%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.62%OPUSDT-3.90%IOTAUSDT-2.72%POLUSDT-2.17%WIFUSDT-2.98%AXSUSDT-3.20%EOSUSDT-4.53%IMXUSDT-3.86%FARTCOINUSDT-7.06%GALAUSDT-2.38%DYDXUSDT-3.30%ORDIUSDT-2.78%NOTUSDT-2.34%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%0700.HK-6.19%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.76%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-1.46%UNH-10.21%1288.HK-1.64%PM-0.85%0005.HK-2.09%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.56%EURAUD+1.01%AUDCHF-0.99%AUDCAD-0.99%GBPAUD+0.93%AUDNZD-0.88%NZDJPY-0.82%GBPJPY-0.76%CADJPY-0.71%EURJPY-0.71%CHFJPY-0.70%NZDUSD-0.67%AUDSGD-0.62%GBPUSD-0.61%USDCHF+0.60%USDCAD+0.58%AUDDKK-0.56%EURUSD-0.56%USDZAR+0.44%GBPTRY+0.41%USDMXN+0.41%AUDNOK-0.37%USDTHB+0.35%NZDMXN+0.32%GBPHKD+0.32%EURZAR+0.31%USDNOK+0.30%GBPMXN-0.28%GBPZAR+0.28%CHFNOK+0.26%NOKJPY-0.24%USDTRY+0.21%USDSEK+0.19%EURNOK+0.19%USDPLN+0.17%USDILS+0.16%USDJPY-0.15%EURCNH-0.15%CHFSEK+0.14%EURHKD-0.13%USDCNH-0.12%NZDCAD-0.12%USDDKK+0.12%EURNZD+0.11%NZDCHF-0.11%GBPSGD-0.09%PLNJPY-0.09%EURSEK+0.08%EURGBP+0.06%GBPNZD+0.06%USDSGD+0.06%EURSGD-0.06%GBPCAD-0.05%EURPLN+0.05%EURCZK+0.04%EURCHF+0.04%USDCOP-0.04%SGDJPY+0.02%GBPCHF-0.02%EURCAD+0.02%USDHKD-0.01%CADCHF+0.01%NZDSGD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.14%XAGUSD-0.95%GAGUSD-0.95%XAUUSD-0.64%GAUUSD-0.64%HG1-0.53%W1-0.47%XNGUSD-0.44%C1-0.29%UKOIL+0.28%S1-0.15%USOIL+0.05%BTCUSD-3.70%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.67%ZECUSDT-7.39%XMRUSDT-2.17%DOGEUSD+55.95%LINKUSD-3.57%XLMUSD-3.94%BCHUSDT-3.64%LTCUSD+47.50%UNIUSD-3.19%SUIUSD-3.36%TONUSD+59.18%HBARUSDT-5.48%TAOUSDT-3.60%AAVEUSD-3.76%ONDOUSDT-5.67%ICPUSDT-2.09%DOTUSDT-4.17%WLDUSDT-3.94%ARBUSDT-5.98%ATOMUSDT-2.61%INJUSDT-8.15%STXUSDT-3.46%PYTHUSDT-1.58%TIAUSDT-3.65%FETUSDT-4.91%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.62%OPUSDT-3.90%IOTAUSDT-2.72%POLUSDT-2.17%WIFUSDT-2.98%AXSUSDT-3.20%EOSUSDT-4.53%IMXUSDT-3.86%FARTCOINUSDT-7.06%GALAUSDT-2.38%DYDXUSDT-3.30%ORDIUSDT-2.78%NOTUSDT-2.34%RONINUSDT-2.92%
IM

Immunome, Inc. (IMNM)

NASDAQ • Healthcare

$16.78
-$0.39 (-2.3%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$17.16
Day Range$16.66 - $17.89
Avg. Volume (3M)1.4M
Market Cap$1.9B
52 Week Range
$16.41$30.06

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$282.6M
EPS (TTM)
-$2.65
ROA (TTM)
-55.91%
Current Ratio
11.66

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+20.0%Q2 2026-$0.48
-26.5%Q3 2026-$0.65
-22.2%Q4 2026-$0.76

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Miss -22.2%

Immunome’s loss per share missed expectations, with EPS of -$0.76 trailing the -$0.61 estimate by -$0.15, based on preliminary third fiscal quarter of 2026 results reported November 10, 2026. Net income was a loss of roughly $85.8 million, down -49.3% from a loss of about $57.5 million a year ago, alongside operating income of around -$90.4 million as the company continued investing across its oncology pipeline, including antibody-drug conjugate programs such as Varegacestat and IM-1021. Operating cash flow was negative at about $60.8 million. Compared with the year-ago period, EPS declined -16.9% from -$0.65. For the next period, consensus calls for EPS of -$0.64 on revenue of $153,846.00.

View full earnings history

About Immunome, Inc.

Immunome, Inc. (NASDAQ: IMNM) is a Biotechnology company in the healthcare sector developing oncology therapeutics in the United States. The company is a small-cap drug developer focused on antibody-drug conjugates and related cancer programs, with Varegacestat, IM-1021, and other pipeline assets spanning clinical and preclinical stages.

Name
Immunome, Inc.
CEO
Clay Siegall
Industry
Healthcare
Year Founded
2006
Employees
267

Today's Snapshot

AI-generated

The day ended with IMNM 2.3% lower at 16.78, in line with a weaker sector. IMNM closed within 2.2% of its 52-week low of 16.41.

Trading Volume

Above 10d avg 1.4M

1.4M

vs S&P 500 Today

Underperforming Market

-2.07%

Updated: November 18, 2026 at 21:27 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
IMNM shows pronounced technical deterioration as the current price sits below its short-, medium- and long-term moving averages, indicating broad weakness across timeframes. Momentum indicators are negative—RSI in the mid-30s, a sharply negative CCI and a negative MACD—and ATR is relatively high as a percentage of price, reflecting elevated volatility. ADX is modest, suggesting limited trend conviction, while on-balance volume is aligned with selling pressure. The classic pivot lies above the market and offers resistance rather than support. Technical takeaway: the weight of indicators supports a strong-sell stance with persistent selling pressure and price below key averages.
All signals
  • EMA (5 indicators)$18.06 - $21.38
    Sell
  • RSI (14)36.75
    Neutral
  • Stochastic %K (14, 3, 3)4.85
    Buy
  • MACD Level (12, 26)-0.61
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.